Cardiol Therapeutics Inc Class A
About
Cardiol Therapeutics Inc Class A (TO:CRDL) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program
Apr 14 2026
Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart
Apr 1 2026
Cardiol Therapeutics Announces Year-End 2025 Update on Operations
Feb 25 2026
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference
Feb 10 2026
Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure
Recent Videos
𝗖𝗔𝗥𝗗𝗜𝗢𝗟 𝗧𝗛𝗘𝗥𝗔𝗣𝗘𝗨𝗧𝗜𝗖𝗦 (𝗖𝗥𝗗𝗟) 𝗦𝗢𝗔𝗥𝗦 𝗢𝗡 𝗣𝗛𝗔𝗦𝗘 𝗜𝗜 𝗠𝗬𝗢𝗖𝗔𝗥𝗗𝗜𝗧𝗜𝗦 𝗕𝗥𝗘𝗔𝗞𝗧𝗛𝗥𝗢𝗨𝗚𝗛 | 𝗜𝗡𝗩𝗘𝗦𝗧𝗢𝗥 𝗨𝗣𝗗𝗔𝗧𝗘
Dec 02, 2025
Big strides ahead for Cardiol Therapeutics (CRDL)
Nov 04, 2025
Cardiol Therapeutics CEO on CardiolRx, Clinical Trials & Orphan Drug Status
Sep 22, 2025
Cardiol Therapeutics Inc Stock is steadily moving ahead - crdl stock
Oct 15, 2021
Financials
Revenue
CA$0
Market Cap
CA$221.13 M
EPS
-0.39